23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › NovoCure Limited › 2025-2026

NovoCure Limited 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and NovoCure Limited’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 14Ballot items
  • 255Asset managers, any item
  • 3,195Fund votes
  • June 3, 2026Meeting date

Results at a glance

Meeting of June 3, 2026: 14 items on NovoCure Limited’s Form 8-K, filed June 5, 2026: 11 elected · 3 approved.

Dissent

Significant dissent: 1 equity or compensation plan (49.7% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore NovoCure Limited in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by NovoCure Limited

These tallies are NovoCure Limited’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

NovoCure Limited — official shareholder meeting results, meeting held June 3, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Asaf Danziger 81,489,6091,388,51274,479 --10,874,130 98%Elected—
Elect Director: William Doyle 80,241,0092,664,19047,401 --10,874,130 97%Elected—
Elect Director: Jeryl Hilleman 81,547,8201,293,373111,407 --10,874,130 98%Elected—
Elect Director: David Hung 80,768,3252,039,529144,746 --10,874,130 98%Elected—
Elect Director: Frank Leonard 82,547,254356,49448,852 --10,874,130 99.6%Elected—
Elect Director: Kinyip Gabriel Leung 79,455,7543,370,420126,426 --10,874,130 96%Elected—
Elect Director: Martin Madden 81,360,6411,461,539130,420 --10,874,130 98%Elected—
Elect Director: Allyson Ocean 81,178,2951,666,945107,360 --10,874,130 98%Elected—
Elect Director: Timothy Scannell 81,540,5311,292,301119,768 --10,874,130 98%Elected—
Elect Director: Kristin Stafford 81,584,3981,272,04596,157 --10,874,130 98%Elected—
Elect Director: William Vernon 81,349,4101,483,356119,834 --10,874,130 98%Elected—
2. Ratification of Independent Registered Public Accounting Firm 91,436,9102,337,25552,565 ---- 98%Approved—
3. Approval of a non-binding advisory vote to approve executive compensation 75,392,1687,422,876137,556 --10,874,130 91%Approved—
4. Approval of the Company's Amended and Restated 2024 Omnibus Incentive Plan 41,680,62241,161,139110,839 --10,874,130 50.3%Approved—

Source: NovoCure Limited, Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.

How asset managers voted at the NovoCure Limited 2025-2026 meeting

255 asset managers disclosed a vote on at least one NovoCure Limited item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Allyson Ocean

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 81,178,295AGAINST: 1,666,945

Prior year: 99.4% for (June 4, 2025 meeting) ▼ 1.4 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: Allyson Ocean

NovoCure Limited’s own tally for this item (“Elect Director: Allyson Ocean”): 81,178,295 for, 1,666,945 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,287,812 for, 4 against, 18,379 abstained.

FOR
FOR: 33,287,812AGAINST: 4ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: Allyson Ocean” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,893,2484 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust57,3790 00For
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: Asaf Danziger

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 81,489,609AGAINST: 1,388,512

Prior year: 99.1% for (June 4, 2025 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: Asaf Danziger

NovoCure Limited’s own tally for this item (“Elect Director: Asaf Danziger”): 81,489,609 for, 1,388,512 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,171,659 for, 116,157 against, 18,379 abstained.

FOR
FOR: 33,171,659AGAINST: 116,157ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: Asaf Danziger” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,884,4438,809 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust057,379 00Against
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: David Hung

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 80,768,325AGAINST: 2,039,529

Prior year: 99.4% for (June 4, 2025 meeting) ▼ 1.8 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: David Hung

NovoCure Limited’s own tally for this item (“Elect Director: David Hung”): 80,768,325 for, 2,039,529 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,171,658 for, 116,158 against, 18,379 abstained.

FOR
FOR: 33,171,658AGAINST: 116,158ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: David Hung” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,884,4428,810 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust057,379 00Against
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: Frank Leonard

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 82,547,254AGAINST: 356,494
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: Frank Leonard

NovoCure Limited’s own tally for this item (“Elect Director: Frank Leonard”): 82,547,254 for, 356,494 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,287,815 for, 1 against, 18,379 abstained.

FOR
FOR: 33,287,815AGAINST: 1ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: Frank Leonard” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,893,2511 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust57,3790 00For
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: Jeryl Hilleman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 81,547,820AGAINST: 1,293,373

Prior year: 99.4% for (June 4, 2025 meeting) ▼ 1.0 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: Jeryl Hilleman

NovoCure Limited’s own tally for this item (“Elect Director: Jeryl Hilleman”): 81,547,820 for, 1,293,373 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,171,659 for, 116,157 against, 18,379 abstained.

FOR
FOR: 33,171,659AGAINST: 116,157ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: Jeryl Hilleman” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,884,4438,809 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust057,379 00Against
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: Kinyip Gabriel Leung

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 79,455,754AGAINST: 3,370,420

Prior year: 98.2% for (June 4, 2025 meeting) ▼ 2.3 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: Kinyip Gabriel Leung

NovoCure Limited’s own tally for this item (“Elect Director: Kinyip Gabriel Leung”): 79,455,754 for, 3,370,420 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,124,399 for, 163,417 against, 18,379 abstained.

FOR
FOR: 33,124,399AGAINST: 163,417ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: Kinyip Gabriel Leung” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,879,24714,005 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X60,42733,575 00Mixed
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust057,379 00Against
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: Kristin Stafford

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 81,584,398AGAINST: 1,272,045

Prior year: 99.4% for (June 4, 2025 meeting) ▼ 1.0 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: Kristin Stafford

NovoCure Limited’s own tally for this item (“Elect Director: Kristin Stafford”): 81,584,398 for, 1,272,045 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,287,813 for, 3 against, 18,379 abstained.

FOR
FOR: 33,287,813AGAINST: 3ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: Kristin Stafford” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,893,2493 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust57,3790 00For
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: Martin Madden

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 81,360,641AGAINST: 1,461,539

Prior year: 99.4% for (June 4, 2025 meeting) ▼ 1.2 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: Martin Madden

NovoCure Limited’s own tally for this item (“Elect Director: Martin Madden”): 81,360,641 for, 1,461,539 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,287,813 for, 3 against, 18,379 abstained.

FOR
FOR: 33,287,813AGAINST: 3ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: Martin Madden” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,893,2493 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust57,3790 00For
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: Timothy Scannell

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 81,540,531AGAINST: 1,292,301

Prior year: 99.4% for (June 4, 2025 meeting) ▼ 1.0 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: Timothy Scannell

NovoCure Limited’s own tally for this item (“Elect Director: Timothy Scannell”): 81,540,531 for, 1,292,301 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,171,659 for, 116,157 against, 18,379 abstained.

FOR
FOR: 33,171,659AGAINST: 116,157ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: Timothy Scannell” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,884,4438,809 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust057,379 00Against
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: William Doyle

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 80,241,009AGAINST: 2,664,190

Prior year: 99.0% for (June 4, 2025 meeting) ▼ 2.2 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: William Doyle

NovoCure Limited’s own tally for this item (“Elect Director: William Doyle”): 80,241,009 for, 2,664,190 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,132,889 for, 154,927 against, 18,379 abstained.

FOR
FOR: 33,132,889AGAINST: 154,927ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: William Doyle” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,879,24814,004 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X60,42733,575 00Mixed
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust057,379 00Against
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Elect Director: William Vernon

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 81,349,410AGAINST: 1,483,356

Prior year: 98.7% for (June 4, 2025 meeting) ▼ 0.5 pts

Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: William Vernon

NovoCure Limited’s own tally for this item (“Elect Director: William Vernon”): 81,349,410 for, 1,483,356 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The eleven nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 33,171,659 for, 116,157 against, 18,379 abstained.

FOR
FOR: 33,171,659AGAINST: 116,157ABSTAIN: 18,379
Largest asset managers voting on “Election of Directors: William Vernon” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,884,4438,809 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust057,379 00Against
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).

Approval of the Company's Amended and Restated 2024 Omnibus Incentive Plan

Official resultCOMPENSATIONReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

50.3% Approved · of votes cast

FOR 50.3%AGAINST
FOR: 41,680,622AGAINST: 41,161,139
Details: description as filed, official tally, votes by 63 asset managers

Description as filed by funds: THE APPROVAL OF OUR AMENDED AND RESTATED 2024 OMNIBUS INCENTIVE PLAN.

NovoCure Limited’s own tally for this item (“4. Approval of the Company's Amended and Restated 2024 Omnibus Incentive Plan”): 41,680,622 for, 41,161,139 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve the Company's Amended and Restated 2024 Omnibus Incentive Plan was approved as an ordinary resolution based upon the following votes:”
Support: 50.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 63 asset managers below reported 13,495,550 for, 19,937,204 against, 18,379 abstained.

FORAGAINST
FOR: 13,495,550AGAINST: 19,937,204ABSTAIN: 18,379
Largest asset managers voting on “THE APPROVAL OF OUR AMENDED AND RESTATED 2024 OMNIBUS INCENTIVE PLAN.” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity47,15011,223,363 00Against
Vanguard6,257,1304,636,121 00Mixed
BlackRock4,694,3051,585,752 00Mixed
TIAA0861,235 00Against
Charles Schwab837,8140 00For
T. Rowe Price577,29817,464 00For
Dimensional0299,380 00Against
Equitable147,39790,450 00Mixed
State Street176,3130 00For
Lincoln Financial83,09651,131 00Mixed
American Century0120,517 00Against
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam0113,625 00Against
Eversept Partners, LP111,6400 00For
JPMorgan100,4120 00For
First Trust094,248 00Against
Global X94,0020 00For
EXCHANGE TRADED CONCEPTS TRUST069,407 00Against
AIG/SunAmerica064,208 00Against
1290 Funds064,088 00Against
DWS063,324 00Against
Amplify ETF Trust057,379 00Against
Pacific Life34,71120,959 00Mixed
MASTER INVESTMENT PORTFOLIO053,827 00Against
PACE SELECT ADVISORS TRUST052,709 00Against

Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).

Approval of a non-binding advisory vote to approve executive compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

91% Approved · of votes cast

FOR 91%
FOR: 75,392,168AGAINST: 7,422,876

Prior year: 97.5% for (June 4, 2025 meeting) ▼ 6.5 pts

Details: description as filed, official tally, votes by 248 asset managers

Description as filed by funds: A non-binding advisory vote to approve executive compensation.

NovoCure Limited’s own tally for this item (“3. Approval of a non-binding advisory vote to approve executive compensation”): 75,392,168 for, 7,422,876 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve executive compensation on a non-binding advisory basis was approved as an ordinary resolution based upon the following votes:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of NovoCure Limited’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION” (8 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 59 asset managers voting on “A non-binding advisory vote to approve executive compensation.” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,879,23814,013 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional0299,380 00Against
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial130,6593,568 00For
American Century0120,517 00Against
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X094,002 00Against
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust057,379 00Against
Pacific Life34,71120,959 00Mixed
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Fund voting reports, all 59 managers: 32,426,782 for, 824,033 against, 18,379 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 211 asset managers voting on “A non-binding advisory vote to approve executive compensation.” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity17,055,3400 00For
Soleus Capital Management, L.P.7,585,2090 00For
BlackRock6,046,08018,599 00For
WELLS FARGO CLEARING SERVICES, LLC2,908,8130 00For
GEODE CAPITAL MANAGEMENT, LLC2,422,2980 00For
State Street2,236,388436 00For
Palo Alto Investors LP1,280,4390 00For
T. Rowe Price1,229,1420 00For
C WorldWide Asset Management Fondsmaeglerselskab A/S0971,784 00Against
JACOBS LEVY EQUITY MANAGEMENT, INC956,3220 00For
Vanguard883,2150 00For
Nuveen872,7950 00For
Charles Schwab838,0200 00For
Northern Trust814,1760 00For
BAILLIE GIFFORD & CO LTD727,0320 00For
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND726,4000 00For
Point72642,6690 00For
BNP Paribas Asset Management Holding S.A.0509,642 00Against
SILVERCREST ASSET MANAGEMENT GROUP LLC0486,467 00Against
DE Shaw431,5600 00For
Renaissance388,2310 00For
Connor, Clark & Lunn Investment Management Ltd.372,7910 00For
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM0329,416 00Against
Legal & General Investment Management Ltd0321,985 00Against
MELLON INVESTMENTS Corp0289,256 00Against

Institutional-manager reports, all 211 managers: 51,028,331 for, 4,622,082 against, 12 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

98% Approved · of votes cast

FOR 98%
FOR: 91,436,910AGAINST: 2,337,255

Prior year: 98.7% for (June 4, 2025 meeting) ▼ 1.2 pts

Details: description as filed, official tally, votes by 59 asset managers

Description as filed by funds: THE APPROVAL AND RATIFICATION OF THE APPOINTMENT, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, AS THE AUDITOR AND INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE COMPANY'S FISCAL YEAR ENDING DECEMBER 31, 2026.

NovoCure Limited’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 91,436,910 for, 2,337,255 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve and ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the fiscal year ending December 31, …”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 59 asset managers below reported 33,104,697 for, 146,119 against, 18,379 abstained.

FOR
FOR: 33,104,697AGAINST: 146,119ABSTAIN: 18,379
Largest asset managers voting on “THE APPROVAL AND RATIFICATION OF THE APPOINTMENT, BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS, OF KOST FO” at NovoCure Limited, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,270,5130 00For
Vanguard10,888,0565,196 00For
BlackRock6,280,0570 00For
TIAA861,2350 00For
Charles Schwab837,8140 00For
T. Rowe Price594,7620 00For
Dimensional299,3800 00For
Equitable237,8470 00For
State Street176,3130 00For
Lincoln Financial134,2270 00For
American Century120,5170 00For
QUANTITATIVE MASTER SERIES LLC119,2290 00For
Putnam113,6250 00For
JPMorgan100,4120 00For
First Trust94,2480 00For
Global X60,42733,575 00Mixed
EXCHANGE TRADED CONCEPTS TRUST69,4070 00For
AIG/SunAmerica64,2080 00For
1290 Funds64,0880 00For
DWS63,3240 00For
Amplify ETF Trust057,379 00Against
Pacific Life55,6700 00For
MASTER INVESTMENT PORTFOLIO53,8270 00For
PACE SELECT ADVISORS TRUST52,7090 00For
Northern Trust49,4400 00For

Showing the 25 largest of 59 asset managers. All 59 are in the interactive database (link above).

Largest NovoCure Limited shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 115,820,940 shares outstanding at the time of that meeting.

Fund voting reports: top NovoCure Limited shareholders by shares voted on “THE APPROVAL OF OUR AMENDED AND RESTATED 2024 OMNIBUS INCENTIVE PLAN.”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 9.73%
2Vanguard 9.41%
3BlackRock 5.42%
4TIAA 0.74%
5Charles Schwab 0.72%
6T. Rowe Price 0.51%
7Dimensional 0.26%
8Equitable 0.21%
9State Street 0.15%
10Lincoln Financial 0.12%
Institutional-manager reports: top NovoCure Limited shareholders by shares voted on “A non-binding advisory vote to approve executive compensation.”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 14.73%
2Soleus Capital Management, L.P. 6.55%
3BlackRock 5.24%
4WELLS FARGO CLEARING SERVICES, LLC 2.51%
5GEODE CAPITAL MANAGEMENT, LLC 2.09%
6State Street 1.93%
7Palo Alto Investors LP 1.11%
8T. Rowe Price 1.06%
9C WorldWide Asset Management Fondsmaeglerselskab A/S 0.84%
10JACOBS LEVY EQUITY MANAGEMENT, INC 0.83%

Reported NovoCure Limited holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

NovoCure Limited holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
FMR (Fidelity)17,069,149 14.74%Form 13F, quarter ended March 31, 2026
BlackRock13,193,765 11.39%Form 13F, quarter ended March 31, 2026
Vanguard Group10,958,209 9.46%Form 13F, quarter ended March 31, 2026
Morgan Stanley5,069,895 4.38%Form 13F, quarter ended March 31, 2026
State Street2,561,817 2.21%Form 13F, quarter ended March 31, 2026
Geode Capital2,511,707 2.17%Form 13F, quarter ended March 31, 2026
Renaissance Technologies1,551,554 1.34%Form 13F, quarter ended March 31, 2026
Point721,361,391 1.18%Form 13F, quarter ended March 31, 2026
JPMorgan Chase930,166 0.80%Form 13F, quarter ended March 31, 2026
William Doyle879,573 0.76%Proxy statement (DEF 14A), table as of April 6, 2026

Percentages above are of 115,820,940 shares outstanding, as reported by NovoCure Limited on its Form 10-Q dated April 24, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At NovoCure Limited's shareholder meeting held June 3, 2026, in the 2025-2026 proxy season, 255 asset managers reported votes on at least one of its 14 ballot items in their SEC Form N-PX filings, covering 3,195 separate fund positions. On the most widely held item on that ballot — A non-binding advisory vote to approve executive compensation. — NovoCure Limited's filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: NovoCure Limited's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NovoCure Limited’s 10-Q dated April 24, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

NovoCure Limited proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “NovoCure (NVCR) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/novocure-ltd/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.